We are live on
!
Find out more
FFVM
Founders Fund VII Management Portfolio holdings
AUM
$2.03M
1-Year Est. Return
72.34%
This Fund
S&P 500
This Quarter
Est. Return
-21.53%
1 Year Est. Return
+72.34%
3 Year Est. Return
-64.66%
5 Year Est. Return
-90.66%
10 Year Est. Return
–
AUM
$178M
AUM Growth
–
Cap. Flow
+$196M
Cap. Flow
% of AUM
110.05%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbCellera Biologics
ABCL
|
+$173M |
| 2 |
CMPS
Compass Pathways
CMPS
|
+$23.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
FFVM
NA
AICPI
FFVM
SNN
AC
IVSFI
FFGM
Founders Fund VII Management's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Founders Fund VII Management, which disclosed 2 positions worth $178M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is AbCellera Biologics: 3,773,530 shares worth $152M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Founders Fund VII Management's largest Q4 2020 buy was AbCellera Biologics: 3,773,530 shares worth $152M.
- Founders Fund VII Management's ten largest holdings make up 100% of its $178M portfolio in Q4 2020.
- Founders Fund VII Management disclosed 2 positions in Q4 2020, its first 13F filing on record.
Based on Founders Fund VII Management's 13F filing for Q4 2020, filed 16 Feb 2021.